Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine

Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine

<b>Background:</b> The development of effective and safe vaccines and their timely delivery to the public play a crucial role in preventing and managing infectious diseases. Many vaccines have been produced and distributed globally to prevent COVID-19 infection. However, establishing eff...

Full description

Saved in:
Bibliographic Details
Main Authors: Muzaffar Muminov, Nargiza Tsiferova, Egor Pshenichnov, Khusnora Ermatova, Oksana Charishnikova, Alisher Abdullaev, Yuliya Levitskaya, Dilbar Dalimova, Sandhya MVS, Geetanjali Tomar, Ankush Dewle, Pradhnya Choudhari, Aditi Wangikar, Amol Jadhav, Mrunal Mule, Pralhad Wangikar, Ibrokhim Abdurakhmonov, Shahlo Turdikulova
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Vaccines
Subjects:
SARS-CoV-2
RBD
vaccine
antigen
toxicology
immunogenicity
Online Access:https://www.mdpi.com/2076-393X/12/12/1420
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/12/12/1420

Similar Items